Financial Projections - The company expects a net profit of approximately 26,000,000 RMB for 2025, representing a year-on-year increase of over 50%[4] - The net profit attributable to shareholders is projected to grow by 396.60% to 511.20% compared to the previous year[4] Asset Disposal and Income - The asset disposal income from land acquisition is estimated at 56,142.61 million RMB, significantly boosting net profit compared to 938.41 million RMB in the previous year[6] - The company may face a tax rate increase from 15% to 25% due to asset disposal income, potentially resulting in an additional tax payment of around 48,000,000 RMB[11] Loss Projections - The company anticipates a loss of 7,900,000 RMB after deducting non-recurring gains, a decline of 214.28% to 306.68% year-on-year[4] Cost Increases - Depreciation costs are expected to increase by approximately 23,000,000 to 26,000,000 RMB due to the relocation and construction of new facilities[7] - Sales expenses are projected to rise by about 22,000,000 to 24,000,000 RMB as the company expands its HVAC equipment business[8] - Financial expenses are expected to increase by approximately 13,500,000 to 15,500,000 RMB due to new borrowings and reduced interest income[8] - Credit impairment losses are anticipated to rise by about 30,000,000 to 60,000,000 RMB, impacting overall profitability[9] Investor Advisory - The specific financial data for 2025 will be detailed in the annual report, and investors are advised to exercise caution[12]

Financial Performance - The company expects a net profit of approximately -19,000,000 CNY for the year 2025, compared to -4,714.35 million CNY in the same period last year[4] - The net profit after deducting non-recurring gains and losses is projected to be around -19,500,000 CNY, compared to -5,586.76 million CNY in the previous year[4] Market Conditions - The decline in performance is attributed to ongoing market supply-demand imbalances and intense competition, leading to a continuous drop in market sales prices[6] Asset Impairment - The company anticipates a fixed asset impairment provision of approximately 120 million CNY due to impairment testing conducted at the end of the reporting period[6]

Financial Performance - The company expects a net profit loss of between RMB -60,000,000 and -52,500,000 for 2025, representing a year-on-year improvement of 12.49% to 23.43% compared to RMB -68,562,000 in the previous year[3][5]. - Operating revenue is projected to be between RMB 195,000,000 and 215,000,000, slightly down from RMB 201,137,000 in the same period last year[5]. - The company anticipates non-recurring gains and losses of approximately RMB 65,000,000 to 85,000,000, primarily from government subsidies and fair value changes of financial assets, compared to RMB 85,139,400 in the previous year[7]. - The company has identified asset impairment signs, with goodwill and inventory impairment estimated between RMB 70,000,000 and 100,000,000, a decrease of approximately 33% to 53% from RMB 150,000,000 last year[7]. - The performance forecast data is based on preliminary estimates from the company's finance department and has not been audited[17]. - The specific data for the 2025 fiscal year will be detailed in the company's 2025 annual report[17]. - Investors are advised to make cautious decisions and be aware of investment risks[17]. Strategic Initiatives - The company has made significant progress in the healthcare sector, winning key projects in data governance and launching a major internet hospital platform, which lays the foundation for expanding its "Internet + healthcare" market[8][11]. - The company aims to deepen its presence in the healthcare and public service sectors, aligning with national strategies like "Digital China" and "Healthy China 2030" to drive growth[13]. - The company plans to transform its business model from scale expansion to value cultivation, enhancing its service capabilities and expanding its client base in the healthcare sector[13][14]. Research and Development - The company has increased its R&D investment, achieving multiple industry awards and publishing important national standards, with 15 patents granted and 18 research projects submitted[10][11]. Operational Efficiency - The company is focusing on cost reduction and efficiency improvement, successfully lowering overall labor costs and expenses while enhancing operational efficiency[7][12]. - The company is committed to fostering a culture of entrepreneurship and innovation, streamlining management structures to improve decision-making efficiency[15][16].

Financial Projections - The company expects a net profit in the range of -33 million to -17 million CNY for the year 2025, compared to -77.9 million CNY in the previous year[4] - The net profit after deducting non-recurring gains and losses is projected to be between -59 million and -30 million CNY, compared to -95.08 million CNY in the same period last year[4] Inventory and Losses - The decrease in inventory impairment provision is expected to contribute to a reduced net loss compared to the previous year[6] Audit and Reporting - The performance forecast is based on preliminary calculations by the company's finance department and has not been audited by an external auditor[5] - The specific financial data for the year 2025 will be disclosed in the company's annual report[8]

Financial Performance - The estimated net profit attributable to shareholders for 2025 is projected to be a loss between 1.7 billion and 2.46 billion yuan, representing a decline of 80.57% to 161.29% compared to the previous year's loss of 941.49 million yuan[3]. - The net profit after deducting non-recurring gains and losses is expected to be a loss between 1.697 billion and 2.457 billion yuan, a decrease of 80.41% to 161.20% from the previous year's loss of 940.64 million yuan[3]. Factors Affecting Performance - The decline in performance is attributed to factors such as industry contraction, market competition, and a decrease in new order projects, leading to a drop in revenue compared to the previous year[5]. - Fixed costs, including labor, depreciation, and financial expenses, did not decrease proportionally with revenue, exacerbating the financial losses[5]. Risk Management and Strategic Initiatives - The company has taken a cautious approach by conducting comprehensive checks and impairment tests on accounts receivable and contract assets, resulting in significant impairment provisions[5]. - On May 27, 2025, the company lifted the delisting risk warning and continues to focus on smart city construction and operation services, leveraging new technologies like AI and big data[6]. - Strategic cooperation agreements have been signed with China Railway Construction and China Railway Second Bureau to enhance market competitiveness and promote core business development[6]. Investor Guidance - Detailed financial data for 2025 will be disclosed in the annual report, urging investors to make cautious decisions and be aware of investment risks[7].

证券代码：300860 证券简称：锋尚文化 公告编号：2026-001 锋尚文化集团股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本期业绩预计情况 1.业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2.业绩预告情况：预计净利润为负值 单位：万元 | 项 目 | | 本报告期 | | 上年同期 | | --- | --- | --- | --- | --- | | 归属于上市公司股东的净利润 | -1,800 | ～ | -1,200 | 4,177.25 | | 扣除非经常性损益后的净利润 | -5,800 | ～ | -5,200 | -948.47 | 二、与会计师事务所沟通情况 本次业绩预告相关数据未经会计师事务所审计，公司已就业绩预告有关重大事项与会 计师事务所进行了预沟通，公司与会计师事务所在业绩预告方面不存在分歧，具体数据以 审计结果为准。 三、业绩变动原因说明 报告期内，公司整体业绩相比上年下降，主要原因如下： 2.报告期内，预计非经常性损益对净利润的影响金额约为 4 ...

证券代码：002674 证券简称：兴业科技 公告编号：2026-004 兴业皮革科技股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、本期业绩预计情况 四、风险提示 单位：万元 | 项 目 | | | 本会计年度 | | 上年同期 | | --- | --- | --- | --- | --- | --- | | 归属于上市公司股 东的净利润 | | 9,800 | ～ | 12,000 | 14,164.40 | | | 比上年同期 下降 | 30.81% | ～ | 15.28% | | | 扣除非经常性损益 后的净利润 | | 9,300 | ～ | 11,500 | 13,377.03 | | | 比上年同期 下降 | 30.48% | ～ | 14.03% | | | 基本每股收益（元/ 股） | | 0.3309 | ～ | 0.4051 | 0.4846 | 二、与会计师事务所沟通情况 本次业绩预告虽未经会计师事务所审计，但公司已就本次业绩预告有关事项与年审会计 师事务所进行了预沟通，双方对本次业绩预告不存 ...

证券代码：688658 证券简称：悦康药业 公告编号：2026-003 悦康药业集团股份有限公司 2025 年年度业绩预亏公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 1.经财务部门初步测算，悦康药业集团股份有限公司（以下简称"公司"）预 计 2025 年年度实现归属于母公司所有者的净利润为-28,000.00 万元到-23,500.00 万元，与上年同期（法定披露数据）相比，将出现亏损。 2.预计 2025 年年度实现归属于母公司所有者扣除非经常性损益后的净利润 为-30,500.00 万元到-26,000.00 万元。 （三）公司本次业绩预告情况未经注册会计师审计。 二、上年同期业绩情况 （一）2024 年度，利润总额为：15,235.76 万元 归属于母公司所有者的净利润：12,371.70 万元 （二）公司坚定将研发创新置于战略核心地位，持续积极推动新药研发项目。 报告期内，公司 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 一、本期业绩预计情况 证券代码：300359 证券简称：全通教育 公告编号：2026-004 全通教育集团（广东）股份有限公司 2025 年度业绩预告 本期计提 1,217.17 万元信用减值。 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：预计净利润为负值 单位：万元 | 项 | 目 | | 本报告期 | | 上年同期 | | --- | --- | --- | --- | --- | --- | | 归属于上市公司股东的净利润 | | -8,500 | ～ | -6,000 | -10,448.44 | | 扣除非经常性损益后的净利润 | | -9,000 | ～ | -6,500 | -10,525.93 | 二、与会计师事务所沟通情况 本次业绩预告相关数据是公司财务部门初步测算的结果，未经会计师事务所审计。公 司已就业绩预告有关事项与年审会计师事务所进行了预沟通，公司与年审会计师事务所在 本报告期的业绩预告方面不存在分歧。 三、业绩变动原因说明 1 ...

证券代码：300068 证券简称：南都电源 公告编号：2026-008 浙江南都电源动力股份有限公司 2025 年年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1．业绩预告期间：2025 年 01 月 01 日—2025 年 12 月 31 日 2．业绩预告情况：预计净利润为负值 | 项 目 | | 本报告期 | | 上年同期 | | | --- | --- | --- | --- | --- | --- | | 归属于上市公司 股东的净利润 | 亏损：89,000.00 | 万元–125,000.00 | 万元 | 亏损：149,682.68 | 万元 | | 扣除非经常性损 益后的净利润 | 亏损：93,000.00 | 万元–129,000.00 | 万元 | 亏损：173,365.17 | 万元 | | 营业收入 | 700,000.00 | 万元-800,000 万元 | | 798,375.10 | 万元 | | 扣除后营业收入 | 650,000.00 | 万元-750,000.00 | 万元 | 746,0 ...